| Year |
Citation |
Score |
| 2024 |
Chenoweth MJ, Kim YJ, Nollen NL, Hawk LW, Mahoney MC, Lerman C, Knight J, Tyndale RF. Genetic Prediction of Smoking Cessation Medication Side Effects: A Genome-Wide Investigation of Abnormal Dreams on Varenicline. Clinical Pharmacology and Therapeutics. PMID 38369951 DOI: 10.1002/cpt.3210 |
0.318 |
|
| 2023 |
Wanger TJ, de Moura FB, Ashare R, Loughead J, Lukas S, Lerman C, Janes AC. Brain and cortisol responses to smoking cues are linked in tobacco-smoking individuals. Addiction Biology. 28: e13338. PMID 38017638 DOI: 10.1111/adb.13338 |
0.361 |
|
| 2023 |
Giratallah H, Chenoweth MJ, Pouget JG, El-Boraie A, Alsaafin A, Lerman C, Knight J, Tyndale RF. CYP2A6 associates with respiratory disease risk and younger age of diagnosis: a phenome-wide association Mendelian randomization study. Human Molecular Genetics. PMID 37802914 DOI: 10.1093/hmg/ddad172 |
0.303 |
|
| 2023 |
Truong VTT, Green C, Pedroza C, Hwang LY, Rajan SS, Suchting R, Cinciripini P, Tyndale RF, Lerman C. Bayesian regularization to predict neuropsychiatric adverse events in smoking cessation with pharmacotherapy. Bmc Medical Research Methodology. 23: 107. PMID 37118656 DOI: 10.1186/s12874-023-01931-7 |
0.347 |
|
| 2023 |
Chenoweth MJ, Lerman C, Knight J, Tyndale RF. Influence of CYP2A6 genetic variation, nicotine dependence severity, and treatment on smoking cessation success. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 36789481 DOI: 10.1093/ntr/ntac268 |
0.453 |
|
| 2022 |
Han DH, Cho J, Harlow AF, Tackett AP, Vogel EA, Wong M, Barrington-Trimis JL, Lerman C, Unger JB, Leventhal AM. Young adults' beliefs about modern oral nicotine products: Implications for uptake in nonvapers, dual use with e-cigarettes, and use to reduce/quit vaping. Experimental and Clinical Psychopharmacology. PMID 36048111 DOI: 10.1037/pha0000595 |
0.323 |
|
| 2022 |
Lerman C, Hughes-Halbert C, Falcone M, Gosky DM, Jensen RA, Lee KP, Mitchell E, Odunsi K, Pegher JW, Rodriguez E, Sanchez Y, Shaw R, Weiner G, Willman CL. Leadership Diversity and Development in the Nation's Cancer Centers. Journal of the National Cancer Institute. PMID 35897143 DOI: 10.1093/jnci/djac121 |
0.686 |
|
| 2022 |
Vogel EA, Barrington-Trimis JL, Kechter A, Tackett AP, Liu F, Sussman S, Lerman C, Unger JB, Hughes Halbert C, Chaffee BW, Leventhal AM. Differences in Young Adults' Perceptions of and Willingness to Use Nicotine Pouches by Tobacco Use Status. International Journal of Environmental Research and Public Health. 19. PMID 35270385 DOI: 10.3390/ijerph19052685 |
0.326 |
|
| 2022 |
Giannoulis SV, Chenoweth MJ, Saquilayan P, Tyndale RF, Lerman C, Kennedy JL, Zawertailo L, Gonçalves V. Examining the role of mitochondrial genetic variation in nicotine dependence. Psychiatry Research. 310: 114452. PMID 35227992 DOI: 10.1016/j.psychres.2022.114452 |
0.349 |
|
| 2021 |
Balfour DJK, Benowitz NL, Colby SM, Hatsukami DK, Lando HA, Leischow SJ, Lerman C, Mermelstein RJ, Niaura R, Perkins KA, Pomerleau OF, Rigotti NA, Swan GE, Warner KE, West R. Balancing Consideration of the Risks and Benefits of E-Cigarettes. American Journal of Public Health. e1-e12. PMID 34410826 DOI: 10.2105/AJPH.2021.306416 |
0.345 |
|
| 2021 |
Giratallah HK, Chenoweth MJ, Addo N, Ahluwalia JS, Cox LS, Lerman C, George TP, Benowitz NL, Tyndale RF. Nicotine metabolite ratio: Comparison of the three urinary versions to the plasma version and nicotine clearance in three clinical studies. Drug and Alcohol Dependence. 223: 108708. PMID 33873029 DOI: 10.1016/j.drugalcdep.2021.108708 |
0.354 |
|
| 2021 |
Schnoll R, Paul Wileyto E, Bauer AM, Fox E, Leone F, Lerman C, Tyndale RF, George TP, Hawk L, Cinciripini P, Quinn M, Purnell J, Hatzell J, Hitsman B. Comparing the Rate of Nicotine Metabolism Among Smokers With Current or Past Major Depressive Disorder. The American Journal On Addictions. PMID 33772971 DOI: 10.1111/ajad.13155 |
0.38 |
|
| 2021 |
Chenoweth MJ, Lerman C, Knight J, Tyndale RF. A genome-wide association study of nausea incidence in varenicline-treated cigarette smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 33713409 DOI: 10.1093/ntr/ntab044 |
0.355 |
|
| 2021 |
Falcone M, Liu L, Farias A, Zhang J, Kang I, Li M, Stern MC, Lerman C. Evidence for racial/ethnic disparities in emergency department visits following breast cancer surgery among women in California: a population-based study. Breast Cancer Research and Treatment. PMID 33675489 DOI: 10.1007/s10549-021-06119-5 |
0.679 |
|
| 2020 |
El-Boraie A, Chenoweth MJ, Pouget JG, Benowitz NL, Fukunaga K, Mushiroda T, Kubo M, Nollen NL, Cox LS, Lerman C, Knight J, Tyndale RF. Transferability Of Ancestry-Specific And Cross-Ancestry CYP2A6 Activity Genetic Risk Scores In African And European Populations. Clinical Pharmacology and Therapeutics. PMID 33300144 DOI: 10.1002/cpt.2135 |
0.302 |
|
| 2020 |
Falcone M, Luo C, Chen Y, Birtwell D, Cheatle M, Duan R, Gabriel PE, He L, Ko EM, Lenz HJ, Mirkovic N, Mowery DL, Ochroch EAA, Paulson ECC, Schriver E, ... ... Lerman C, et al. Risk of persistent opioid use following major surgery in matched samples of patients with and without cancer. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 32859580 DOI: 10.1158/1055-9965.Epi-20-0628 |
0.694 |
|
| 2020 |
Ashare RL, Wileyto EP, Logue-Chamberlain E, Gross R, Tyndale RF, Lerman C, Hawk LW, Cinciripini P, George TP, Lubitz SF, Schnoll R. Patterns of lapses and recoveries during a quit attempt using varenicline and behavioral counseling among smokers with and without HIV. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 32686950 DOI: 10.1037/Adb0000619 |
0.312 |
|
| 2020 |
Schnoll R, Paul Wileyto E, Gross R, Hitsman B, Hawk LW, Cinciripini P, George TP, Benowitz NL, Fen Lubitz S, Ashare R, Tyndale RF, Lerman C. Evaluation of nicotine patch adherence measurement using self-report and saliva cotinine among abstainers in a smoking cessation trial. Drug and Alcohol Dependence. 210: 107967. PMID 32224420 DOI: 10.1016/J.Drugalcdep.2020.107967 |
0.477 |
|
| 2020 |
Buchwald J, Chenoweth MJ, Palviainen T, Zhu G, Benner C, Gordon S, Korhonen T, Ripatti S, Madden PAF, Lehtimäki T, Raitakari OT, Salomaa V, Rose RJ, George TP, Lerman C, et al. Genome-wide association meta-analysis of nicotine metabolism and cigarette consumption measures in smokers of European descent. Molecular Psychiatry. PMID 32157176 DOI: 10.1038/S41380-020-0702-Z |
0.516 |
|
| 2020 |
Siegel SD, Lerman C, Flitter A, Schnoll RA. The Use of the Nicotine Metabolite Ratio as a Biomarker to Personalize Smoking Cessation Treatment: Current Evidence and Future Directions. Cancer Prevention Research (Philadelphia, Pa.). 13: 261-272. PMID 32132120 DOI: 10.1158/1940-6207.Capr-19-0259 |
0.531 |
|
| 2020 |
Cheatle MD, Falcone M, Dhingra L, Lerman C. Independent association of tobacco use with opioid use disorder in patients of European ancestry with chronic non-cancer pain. Drug and Alcohol Dependence. 209: 107901. PMID 32126454 DOI: 10.1016/J.Drugalcdep.2020.107901 |
0.712 |
|
| 2019 |
Frank DW, Cinciripini PM, Deweese MM, Karam-Hage M, Kypriotakis G, Lerman C, Robinson JD, Tyndale RF, Vidrine DJ, Versace F. Toward Precision Medicine for Smoking Cessation: Developing a Neuroimaging-Based Classification Algorithm to Identify Smokers at Higher Risk for Relapse. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31724052 DOI: 10.1093/Ntr/Ntz211 |
0.464 |
|
| 2019 |
Peng AR, Swardfager W, Benowitz NL, Ahluwalia JS, Lerman C, Nollen NL, Tyndale RF. Impact of Early Nausea on Varenicline Adherence and Smoking Cessation. Addiction (Abingdon, England). PMID 31502736 DOI: 10.1111/Add.14810 |
0.467 |
|
| 2019 |
Chen J, Loukola A, Gillespie NA, Peterson R, Jia P, Riley B, Maes H, Dick DM, Kendler KS, Damaj MI, Miles MF, Zhao Z, Li MD, Vink JM, Minica CC, ... ... Lerman C, et al. Genome-Wide Meta-Analyses of FTND and TTFC Phenotypes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31294817 DOI: 10.1093/Ntr/Ntz099 |
0.471 |
|
| 2019 |
Allenby C, Falcone M, Ashare RL, Cao W, Bernardo L, Wileyto EP, Pruessner J, Loughead J, Lerman C. Brain Marker Links Stress and Nicotine Abstinence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 31120113 DOI: 10.1093/Ntr/Ntz077 |
0.739 |
|
| 2019 |
Ashare RL, Thompson M, Leone F, Metzger D, Gross R, Mounzer K, Tyndale RF, Lerman C, Mahoney MC, Cinciripini P, George TP, Collman RG, Schnoll R. Differences in the rate of nicotine metabolism among smokers with and without HIV. Aids (London, England). 33: 1083-1088. PMID 30946162 DOI: 10.1097/Qad.0000000000002127 |
0.432 |
|
| 2019 |
El-Boraie A, Taghavi T, Chenoweth MJ, Fukunaga K, Mushiroda T, Kubo M, Lerman C, Nollen NL, Benowitz NL, Tyndale RF. Evaluation of a weighted genetic risk score for the prediction of biomarkers of CYP2A6 activity. Addiction Biology. PMID 30815984 DOI: 10.1111/Adb.12741 |
0.455 |
|
| 2019 |
Allenby C, Falcone M, Wileyto EP, Cao W, Bernardo L, Ashare RL, Janes A, Loughead J, Lerman C. Neural cue reactivity during acute abstinence predicts short-term smoking relapse. Addiction Biology. PMID 30806013 DOI: 10.1111/Adb.12733 |
0.793 |
|
| 2019 |
Ashare RL, Thompson M, Leone F, Metzger D, Gross R, Mounzer K, Tyndale RF, Lerman C, Mahoney MC, Cinciripini P, George TP, Collman RG, Schnoll R. Differences in the rate of nicotine metabolism among smokers with and without HIV. Aids (London, England). PMID 30649060 DOI: 10.1097/QAD.0000000000002127 |
0.32 |
|
| 2019 |
Robinson JD, Li L, Chen M, Lerman C, Tyndale RF, Schnoll RA, Hawk LW, George TP, Benowitz NL, Cinciripini PM. Evaluating the temporal relationships between withdrawal symptoms and smoking relapse. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. PMID 30614717 DOI: 10.1037/Adb0000434 |
0.484 |
|
| 2019 |
Falcone M, Bernardo L, Wileyto EP, Allenby C, Burke AM, Hamilton R, Cristancho M, Ashare RL, Loughead J, Lerman C. Lack of effect of transcranial direct current stimulation (tDCS) on short-term smoking cessation: Results of a randomized, sham-controlled clinical trial. Drug and Alcohol Dependence. 194: 244-251. PMID 30497056 DOI: 10.1016/J.Drugalcdep.2018.10.016 |
0.763 |
|
| 2019 |
Peng AR, Schnoll R, Lerman C, Tyndale RF. Different measures of varenicline adherence, nicotine metabolite ratio and smoking abstinence Drug Metabolism and Pharmacokinetics. 34: S16-S17. DOI: 10.1016/J.Dmpk.2018.09.077 |
0.52 |
|
| 2018 |
Mercincavage M, Lochbuehler K, Wileyto EP, Benowitz NL, Tyndale RF, Lerman C, Strasser AA. Association of Reduced Nicotine Content Cigarettes With Smoking Behaviors and Biomarkers of Exposure Among Slow and Fast Nicotine Metabolizers: A Nonrandomized Clinical Trial. Jama Network Open. 1. PMID 30627706 DOI: 10.1001/jamanetworkopen.2018.1346 |
0.425 |
|
| 2018 |
To C, Falcone M, Loughead J, Logue-Chamberlain E, Hamilton R, Kable J, Lerman C, Ashare RL. Got chocolate? Bilateral prefrontal cortex stimulation augments chocolate consumption. Appetite. 131: 28-35. PMID 30171915 DOI: 10.1016/J.Appet.2018.08.032 |
0.695 |
|
| 2018 |
Peng AR, Schnoll R, Hawk LW, Cinciripini P, George TP, Lerman C, Tyndale RF. Predicting smoking abstinence with biological and self-report measures of adherence to varenicline: Impact on pharmacogenetic trial outcomes. Drug and Alcohol Dependence. 190: 72-81. PMID 29986268 DOI: 10.1016/J.Drugalcdep.2018.04.035 |
0.37 |
|
| 2018 |
Allenby C, Falcone M, Bernardo L, Wileyto EP, Rostain A, Ramsay JR, Lerman C, Loughead J. Transcranial direct current brain stimulation decreases impulsivity in ADHD. Brain Stimulation. PMID 29885858 DOI: 10.1016/J.Brs.2018.04.016 |
0.7 |
|
| 2018 |
Taghavi T, Novalen M, Lerman C, George TP, Tyndale RF. A comparison of direct and indirect analytical approaches to measuring total nicotine equivalents in urine. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 29853480 DOI: 10.1158/1055-9965.Epi-18-0018 |
0.378 |
|
| 2018 |
Tanner JA, Zhu AZ, Claw KG, Prasad B, Korchina V, Hu J, Doddapaneni H, Muzny DM, Schuetz EG, Lerman C, Thummel KE, Scherer SE, Tyndale RF. Novel CYP2A6 diplotypes identified through next-generation sequencing are associated with in-vitro and in-vivo nicotine metabolism. Pharmacogenetics and Genomics. 28: 7-16. PMID 29232328 DOI: 10.1097/Fpc.0000000000000317 |
0.447 |
|
| 2017 |
Chenoweth MJ, Ware JJ, Zhu AZX, Cole CB, Cox LS, Nollen N, Ahluwalia JS, Benowitz NL, Schnoll RA, Hawk LW, Cinciripini PM, George TP, Lerman C, Knight J, Tyndale RF, et al. Genome-wide association study of a nicotine metabolism biomarker in African American smokers: impact of chromosome 19 genetic influences. Addiction (Abingdon, England). PMID 28921760 DOI: 10.1111/Add.14032 |
0.484 |
|
| 2017 |
Peng AR, Morales M, Wileyto EP, Hawk LW, Cinciripini P, George TP, Benowitz NL, Nollen NL, Lerman C, Tyndale RF, Schnoll R. Measures and predictors of varenicline adherence in the treatment of nicotine dependence. Addictive Behaviors. 75: 122-129. PMID 28728040 DOI: 10.1016/J.Addbeh.2017.07.006 |
0.416 |
|
| 2017 |
Kable JW, Caulfield MK, Falcone M, McConnell M, Bernardo L, Parthasarathi T, Cooper N, Ashare R, Audrain-McGovern J, Hornik R, Diefenbach P, Lee FJ, Lerman C. No Effect of Commercial Cognitive Training on Neural Activity During Decision-Making. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. PMID 28694338 DOI: 10.1523/Jneurosci.2832-16.2017 |
0.702 |
|
| 2017 |
Ashare RL, Lerman C, Tyndale RF, Hawk LW, George TP, Cinciripini P, Schnoll RA. Sleep Disturbance During Smoking Cessation: Withdrawal or Side Effect of Treatment? Journal of Smoking Cessation. 12: 63-70. PMID 28553407 DOI: 10.1017/Jsc.2016.11 |
0.376 |
|
| 2016 |
Loughead J, Falcone M, Wileyto EP, Albelda B, Audrain-McGovern J, Cao W, Kurtz MM, Gur RC, Lerman C. Can brain games help smokers quit?: Results of a randomized clinical trial. Drug and Alcohol Dependence. 168: 112-118. PMID 27635998 DOI: 10.1016/J.Drugalcdep.2016.08.621 |
0.783 |
|
| 2016 |
Rabin RA, Ashare RL, Schnoll RA, Cinciripini PM, Hawk LW, Lerman C, Tyndale RF, George TP. Does cannabis use moderate smoking cessation outcomes in treatment-seeking tobacco smokers? Analysis from a large multi-center trial. The American Journal On Addictions / American Academy of Psychiatrists in Alcoholism and Addictions. PMID 27187893 DOI: 10.1111/Ajad.12382 |
0.5 |
|
| 2016 |
Ross KC, Gubner NR, Tyndale RF, Hawk LW, Lerman C, George TP, Cinciripini P, Schnoll RA, Benowitz NL. Racial differences in the relationship between rate of nicotine metabolism and nicotine intake from cigarette smoking. Pharmacology, Biochemistry, and Behavior. PMID 27180107 DOI: 10.1016/J.Pbb.2016.05.002 |
0.465 |
|
| 2016 |
Ashare RL, Lerman C, Cao W, Falcone M, Bernardo L, Ruparel K, Hopson R, Gur R, Pruessner JC, Loughead J. Nicotine withdrawal alters neural responses to psychosocial stress. Psychopharmacology. PMID 27087432 DOI: 10.1007/S00213-016-4299-5 |
0.757 |
|
| 2016 |
Falcone M, Lee B, Lerman C, Blendy JA. Translational Research on Nicotine Dependence. Current Topics in Behavioral Neurosciences. PMID 26873019 DOI: 10.1007/7854_2015_5005 |
0.767 |
|
| 2016 |
Allenby CE, Boylan KA, Lerman C, Falcone M. Precision Medicine for Tobacco Dependence: Development and Validation of the Nicotine Metabolite Ratio. Journal of Neuroimmune Pharmacology : the Official Journal of the Society On Neuroimmune Pharmacology. 11: 471-83. PMID 26872457 DOI: 10.1007/S11481-016-9656-Y |
0.811 |
|
| 2015 |
Falcone M, Cao W, Bernardo L, Tyndale RF, Loughead J, Lerman C. Brain Responses to Smoking Cues Differ Based on Nicotine Metabolism Rate. Biological Psychiatry. PMID 26805583 DOI: 10.1016/J.Biopsych.2015.11.015 |
0.802 |
|
| 2015 |
Falcone M, Bernardo L, Ashare RL, Hamilton R, Faseyitan O, McKee SA, Loughead J, Lerman C. Transcranial Direct Current Brain Stimulation Increases Ability to Resist Smoking. Brain Stimulation. PMID 26572280 DOI: 10.1016/J.Brs.2015.10.004 |
0.78 |
|
| 2015 |
Dubroff JG, Doot RK, Falcone M, Schnoll RA, Ray R, Tyndale RF, Brody AL, Hou C, Schmitz A, Lerman C. Decreased Nicotinic Receptor Availability in Smokers with Slow Rates of Nicotine Metabolism. Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. 56: 1724-9. PMID 26272810 DOI: 10.2967/Jnumed.115.155002 |
0.801 |
|
| 2015 |
Bergen AW, Michel M, Nishita D, Krasnow R, Javitz HS, Conneely KN, Lessov-Schlaggar CN, Hops H, Zhu AZ, Baurley JW, McClure JB, Hall SM, Baker TB, Conti DV, Benowitz NL, ... Lerman C, et al. Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption. Plos One. 10: e0126113. PMID 26132489 DOI: 10.1371/Journal.Pone.0126113 |
0.456 |
|
| 2015 |
Chenoweth MJ, Schnoll RA, Novalen M, Hawk LW, George TP, Cinciripini PM, Lerman C, Tyndale RF. The Nicotine Metabolite Ratio is Associated With Early Smoking Abstinence Even After Controlling for Factors That Influence the Nicotine Metabolite Ratio. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 26069034 DOI: 10.1093/Ntr/Ntv125 |
0.526 |
|
| 2015 |
Tanner JA, Novalen M, Jatlow P, Huestis MA, Murphy SE, Kaprio J, Kankaanpää A, Galanti L, Stefan C, George TP, Benowitz NL, Lerman C, Tyndale RF. Nicotine Metabolite Ratio (3-Hydroxycotinine/Cotinine) in Plasma and Urine by Different Analytical Methods and Laboratories: Implications for Clinical Implementation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. PMID 26014804 DOI: 10.1158/1055-9965.Epi-14-1381 |
0.489 |
|
| 2015 |
Tyndale RF, Zhu AZ, George TP, Cinciripini P, Hawk LW, Schnoll RA, Swan GE, Benowitz NL, Heitjan DF, Lerman C. Lack of Associations of CHRNA5-A3-B4 Genetic Variants with Smoking Cessation Treatment Outcomes in Caucasian Smokers despite Associations with Baseline Smoking. Plos One. 10: e0128109. PMID 26010901 DOI: 10.1371/Journal.Pone.0128109 |
0.497 |
|
| 2015 |
Perkins KA, Karelitz JL, Michael VC, Fromuth M, Conklin CA, Chengappa KN, Hope C, Lerman C. Initial Evaluation of Fenofibrate for Efficacy in Aiding Smoking Abstinence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 25895948 DOI: 10.1093/Ntr/Ntv085 |
0.451 |
|
| 2015 |
Hamilton DA, Mahoney MC, Novalen M, Chenoweth MJ, Heitjan DF, Lerman C, Tyndale RF, Hawk LW. Test-Retest Reliability and Stability of the Nicotine Metabolite Ratio Among Treatment-Seeking Smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. PMID 25732567 DOI: 10.1093/Ntr/Ntv031 |
0.467 |
|
| 2015 |
Lerman C, Schnoll RA, Hawk LW, Cinciripini P, George TP, Wileyto EP, Swan GE, Benowitz NL, Heitjan DF, Tyndale RF. Use of the nicotine metabolite ratio as a genetically informed biomarker of response to nicotine patch or varenicline for smoking cessation: a randomised, double-blind placebo-controlled trial. The Lancet. Respiratory Medicine. 3: 131-8. PMID 25588294 DOI: 10.1016/S2213-2600(14)70294-2 |
0.527 |
|
| 2015 |
Loughead J, Wileyto EP, Ruparel K, Falcone M, Hopson R, Gur R, Lerman C. Working memory-related neural activity predicts future smoking relapse. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 40: 1311-20. PMID 25469682 DOI: 10.1038/Npp.2014.318 |
0.789 |
|
| 2014 |
Chenoweth MJ, Novalen M, Hawk LW, Schnoll RA, George TP, Cinciripini PM, Lerman C, Tyndale RF. Known and novel sources of variability in the nicotine metabolite ratio in a large sample of treatment-seeking smokers. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 23: 1773-82. PMID 25012994 DOI: 10.1158/1055-9965.Epi-14-0427 |
0.494 |
|
| 2014 |
Leventhal AM, Lee W, Bergen AW, Swan GE, Tyndale RF, Lerman C, Conti DV. Nicotine dependence as a moderator of genetic influences on smoking cessation treatment outcome. Drug and Alcohol Dependence. 138: 109-17. PMID 24667010 DOI: 10.1016/J.Drugalcdep.2014.02.016 |
0.522 |
|
| 2014 |
Lerman C, Gu H, Loughead J, Ruparel K, Yang Y, Stein EA. Large-scale brain network coupling predicts acute nicotine abstinence effects on craving and cognitive function. Jama Psychiatry. 71: 523-30. PMID 24622915 DOI: 10.1001/Jamapsychiatry.2013.4091 |
0.431 |
|
| 2014 |
Perkins KA, Lerman C. An efficient early phase 2 procedure to screen medications for efficacy in smoking cessation. Psychopharmacology. 231: 1-11. PMID 24297304 DOI: 10.1007/S00213-013-3364-6 |
0.391 |
|
| 2014 |
Turner JR, Ray R, Lee B, Everett L, Xiang J, Jepson C, Kaestner KH, Lerman C, Blendy JA. Evidence from mouse and man for a role of neuregulin 3 in nicotine dependence. Molecular Psychiatry. 19: 801-10. PMID 23999525 DOI: 10.1038/Mp.2013.104 |
0.765 |
|
| 2014 |
Ashare RL, Falcone M, Lerman C. Cognitive function during nicotine withdrawal: Implications for nicotine dependence treatment. Neuropharmacology. 76: 581-91. PMID 23639437 DOI: 10.1016/J.Neuropharm.2013.04.034 |
0.762 |
|
| 2014 |
Falcone M, Wileyto EP, Ruparel K, Gerraty RT, LaPrate L, Detre JA, Gur R, Loughead J, Lerman C. Age-related differences in working memory deficits during nicotine withdrawal. Addiction Biology. 19: 907-17. PMID 23496760 DOI: 10.1111/Adb.12051 |
0.787 |
|
| 2013 |
Parvanta S, Gibson L, Forquer H, Shapiro-Luft D, Dean L, Freres D, Lerman C, Mallya G, Moldovan-Johnson M, Tan A, Cappella J, Hornik R. Applying Quantitative Approaches to the Formative Evaluation of Antismoking Campaign Messages. Social Marketing Quarterly. 19: 242-264. PMID 24817829 DOI: 10.1177/1524500413506004 |
0.309 |
|
| 2013 |
Ashare RL, Wileyto EP, Ruparel K, Goelz PM, Hopson RD, Valdez JN, Gur RC, Loughead J, Lerman C. Effects of tolcapone on working memory and brain activity in abstinent smokers: a proof-of-concept study. Drug and Alcohol Dependence. 133: 852-6. PMID 24095246 DOI: 10.1016/J.Drugalcdep.2013.09.003 |
0.416 |
|
| 2013 |
David SP, Strong DR, Leventhal AM, Lancaster MA, McGeary JE, Munafò MR, Bergen AW, Swan GE, Benowitz NL, Tyndale RF, Conti DV, Brown RA, Lerman C, Niaura R. Influence of a dopamine pathway additive genetic efficacy score on smoking cessation: results from two randomized clinical trials of bupropion. Addiction (Abingdon, England). 108: 2202-11. PMID 23941313 DOI: 10.1111/Add.12325 |
0.48 |
|
| 2013 |
Ashare RL, Valdez JN, Ruparel K, Albelda B, Hopson RD, Keefe JR, Loughead J, Lerman C. Association of abstinence-induced alterations in working memory function and COMT genotype in smokers. Psychopharmacology. 230: 653-62. PMID 23828159 DOI: 10.1007/S00213-013-3197-3 |
0.376 |
|
| 2013 |
Falcone M, Smith RM, Chenoweth MJ, Bhattacharjee AK, Kelsoe JR, Tyndale RF, Lerman C. Neuroimaging in psychiatric pharmacogenetics research: the promise and pitfalls. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 38: 2327-37. PMID 23793356 DOI: 10.1038/Npp.2013.152 |
0.717 |
|
| 2013 |
Perkins KA, Lerman C, Karelitz JL, Jao NC, Chengappa KN, Sparks GM. Sensitivity and specificity of a procedure for early human screening of novel smoking cessation medications. Addiction (Abingdon, England). 108: 1962-8. PMID 23773319 DOI: 10.1111/Add.12273 |
0.428 |
|
| 2013 |
Falcone M, Lerman C, Cappella JN, Sanborn P, Jepson C, Strasser AA. No untoward effects of smoking cues in anti-smoking public service announcements. Drug and Alcohol Dependence. 133: 279-82. PMID 23742844 DOI: 10.1016/J.Drugalcdep.2013.05.006 |
0.786 |
|
| 2013 |
Perkins KA, Karelitz JL, Jao NC, Gur RC, Lerman C. Effects of bupropion on cognitive performance during initial tobacco abstinence. Drug and Alcohol Dependence. 133: 283-6. PMID 23726977 DOI: 10.1016/J.Drugalcdep.2013.05.003 |
0.454 |
|
| 2013 |
Wang AL, Ruparel K, Loughead JW, Strasser AA, Blady SJ, Lynch KG, Romer D, Cappella JN, Lerman C, Langleben DD. Content matters: neuroimaging investigation of brain and behavioral impact of televised anti-tobacco public service announcements. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 33: 7420-7. PMID 23616548 DOI: 10.1523/Jneurosci.3840-12.2013 |
0.417 |
|
| 2013 |
Bough KJ, Lerman C, Rose JE, McClernon FJ, Kenny PJ, Tyndale RF, David SP, Stein EA, Uhl GR, Conti DV, Green C, Amur S. Biomarkers for smoking cessation. Clinical Pharmacology and Therapeutics. 93: 526-38. PMID 23588313 DOI: 10.1038/Clpt.2013.57 |
0.403 |
|
| 2013 |
Zhu AZ, Renner CC, Hatsukami DK, Swan GE, Lerman C, Benowitz NL, Tyndale RF. The ability of plasma cotinine to predict nicotine and carcinogen exposure is altered by differences in CYP2A6: the influence of genetics, race, and sex. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 22: 708-18. PMID 23371292 DOI: 10.1158/1055-9965.Epi-12-1234-T |
0.429 |
|
| 2013 |
Bergen AW, Javitz HS, Krasnow R, Nishita D, Michel M, Conti DV, Liu J, Lee W, Edlund CK, Hall S, Kwok PY, Benowitz NL, Baker TB, Tyndale RF, Lerman C, et al. Nicotinic acetylcholine receptor variation and response to smoking cessation therapies. Pharmacogenetics and Genomics. 23: 94-103. PMID 23249876 DOI: 10.1097/Fpc.0B013E32835Cdabd |
0.501 |
|
| 2013 |
Bergen AW, Javitz HS, Su L, He Y, Conti DV, Benowitz NL, Tyndale RF, Lerman C, Swan GE. The DRD4 exon III VNTR, bupropion, and associations with prospective abstinence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 15: 1190-200. PMID 23212438 DOI: 10.1093/Ntr/Nts245 |
0.365 |
|
| 2013 |
Lee S, Cappella JN, Lerman C, Strasser AA. Effects of smoking cues and argument strength of antismoking advertisements on former smokers' self-efficacy, attitude, and intention to refrain from smoking. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 15: 527-33. PMID 22949578 DOI: 10.1093/Ntr/Nts171 |
0.487 |
|
| 2013 |
Loughead J, Ray R, Wileyto EP, Ruparel K, O'Donnell GP, Senecal N, Siegel S, Gur RC, Lerman C. Brain activity and emotional processing in smokers treated with varenicline. Addiction Biology. 18: 732-8. PMID 21507156 DOI: 10.1111/J.1369-1600.2011.00324.X |
0.693 |
|
| 2012 |
Ashare RL, Karlawish JH, Wileyto EP, Pinto A, Lerman C. APOE ɛ4, an Alzheimer's disease susceptibility allele, and smoking cessation. The Pharmacogenomics Journal. 13: 538-43. PMID 23247396 DOI: 10.1038/Tpj.2012.49 |
0.481 |
|
| 2012 |
Featherstone RE, Phillips JM, Thieu T, Ehrlichman RS, Halene TB, Leiser SC, Christian E, Johnson E, Lerman C, Siegel SJ. Nicotine receptor subtype-specific effects on auditory evoked oscillations and potentials. Plos One. 7: e39775. PMID 22911690 DOI: 10.1371/Journal.Pone.0039775 |
0.403 |
|
| 2012 |
Kim HS, Bigman CA, Leader AE, Lerman C, Cappella JN. Narrative Health Communication and Behavior Change: The Influence of Exemplars in the News on Intention to Quit Smoking. The Journal of Communication. 62: 473-492. PMID 22736808 DOI: 10.1111/J.1460-2466.2012.01644.X |
0.464 |
|
| 2012 |
Ashare RL, Ray R, Lerman C, Strasser AA. Cognitive effects of the acetylcholinesterase inhibitor, donepezil, in healthy, non-treatment seeking smokers: a pilot feasibility study. Drug and Alcohol Dependence. 126: 263-7. PMID 22595038 DOI: 10.1016/J.Drugalcdep.2012.04.019 |
0.732 |
|
| 2012 |
Lee W, Ray R, Bergen AW, Swan GE, Thomas P, Tyndale RF, Benowitz NL, Lerman C, Conti DV. DRD1 associations with smoking abstinence across slow and normal nicotine metabolizers. Pharmacogenetics and Genomics. 22: 551-4. PMID 22495174 DOI: 10.1097/Fpc.0B013E3283539062 |
0.765 |
|
| 2012 |
Perkins KA, Giedgowd GE, Karelitz JL, Conklin CA, Lerman C. Smoking in response to negative mood in men versus women as a function of distress tolerance. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 14: 1418-25. PMID 22416115 DOI: 10.1093/Ntr/Nts075 |
0.44 |
|
| 2012 |
Falcone M, Gold AB, Wileyto EP, Ray R, Ruparel K, Newberg A, Dubroff J, Logan J, Zubieta JK, Blendy JA, Lerman C. μ-Opioid receptor availability in the amygdala is associated with smoking for negative affect relief. Psychopharmacology. 222: 701-8. PMID 22389047 DOI: 10.1007/S00213-012-2673-5 |
0.831 |
|
| 2012 |
Gold AB, Wileyto EP, Lori A, Conti D, Cubells JF, Lerman C. Pharmacogenetic association of the galanin receptor (GALR1) SNP rs2717162 with smoking cessation. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 1683-8. PMID 22373943 DOI: 10.1038/Npp.2012.13 |
0.514 |
|
| 2012 |
Javitz HS, Lerman C, Swan GE. Comparative dynamics of four smoking withdrawal symptom scales Addiction. 107: 1501-1511. PMID 22321019 DOI: 10.1111/J.1360-0443.2012.03838.X |
0.467 |
|
| 2012 |
Cao YA, Featherstone RE, Gandal MJ, Liang Y, Jutzeler C, Saunders J, Tatard-Leitman V, Chen J, Weinberger DR, Lerman C, Siegel SJ. Nicotine normalizes event related potentials in COMT-Val-tg mice and increases gamma and theta spectral density. Behavioral Neuroscience. 126: 332-43. PMID 22309446 DOI: 10.1037/A0027047 |
0.393 |
|
| 2012 |
Gold AB, Lerman C. Pharmacogenetics of smoking cessation: role of nicotine target and metabolism genes. Human Genetics. PMID 22290489 DOI: 10.1007/S00439-012-1143-9 |
0.547 |
|
| 2012 |
Schnoll RA, Wileyto EP, Lerman C. Extended duration therapy with transdermal nicotine may attenuate weight gain following smoking cessation. Addictive Behaviors. 37: 565-8. PMID 22244706 DOI: 10.1016/J.Addbeh.2011.12.009 |
0.521 |
|
| 2012 |
King DP, Paciga S, Pickering E, Benowitz NL, Bierut LJ, Conti DV, Kaprio J, Lerman C, Park PW. Smoking cessation pharmacogenetics: analysis of varenicline and bupropion in placebo-controlled clinical trials. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 37: 641-50. PMID 22048466 DOI: 10.1038/Npp.2011.232 |
0.526 |
|
| 2012 |
Lee W, Bergen AW, Swan GE, Li D, Liu J, Thomas P, Tyndale RF, Benowitz NL, Lerman C, Conti DV. Gender-stratified gene and gene-treatment interactions in smoking cessation. The Pharmacogenomics Journal. 12: 521-32. PMID 21808284 DOI: 10.1038/Tpj.2011.30 |
0.448 |
|
| 2011 |
Falcone M, Jepson C, Sanborn P, Cappella JN, Lerman C, Strasser AA. Association of BDNF and COMT genotypes with cognitive processing of anti-smoking PSAs Genes, Brain and Behavior. 10: 862-867. PMID 21883922 DOI: 10.1111/J.1601-183X.2011.00726.X |
0.773 |
|
| 2011 |
Schnoll RA, Cappella J, Lerman C, Pinto A, Patterson F, Wileyto EP, Bigman C, Leone F. A novel recruitment message to increase enrollment into a smoking cessation treatment program: preliminary results from a randomized trial. Health Communication. 26: 735-42. PMID 21667366 DOI: 10.1080/10410236.2011.566829 |
0.489 |
|
| 2011 |
Ray R, Ruparel K, Newberg A, Wileyto EP, Loughead JW, Divgi C, Blendy JA, Logan J, Zubieta JK, Lerman C. Human Mu Opioid Receptor (OPRM1 A118G) polymorphism is associated with brain mu-opioid receptor binding potential in smokers. Proceedings of the National Academy of Sciences of the United States of America. 108: 9268-73. PMID 21576462 DOI: 10.1073/Pnas.1018699108 |
0.737 |
|
| 2011 |
Javitz HS, Swan GE, Lerman C. The dynamics of the urge-to-smoke following smoking cessation via pharmacotherapy. Addiction (Abingdon, England). 106: 1835-45. PMID 21561501 DOI: 10.1111/J.1360-0443.2011.03495.X |
0.479 |
|
| 2011 |
Falcone M, Jepson C, Benowitz N, Bergen AW, Pinto A, Wileyto EP, Baldwin D, Tyndale RF, Lerman C, Ray R. Association of the nicotine metabolite ratio and CHRNA5/CHRNA3 polymorphisms with smoking rate among treatment-seeking smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 13: 498-503. PMID 21385908 DOI: 10.1093/Ntr/Ntr012 |
0.804 |
|
| 2011 |
Lee S, Cappella JN, Lerman C, Strasser AA. Smoking cues, argument strength, and perceived effectiveness of antismoking PSAs. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 13: 282-90. PMID 21330273 DOI: 10.1093/Ntr/Ntq255 |
0.466 |
|
| 2011 |
Strasser AA, Benowitz NL, Pinto AG, Tang KZ, Hecht SS, Carmella SG, Tyndale RF, Lerman CE. Nicotine metabolite ratio predicts smoking topography and carcinogen biomarker level. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 20: 234-8. PMID 21212060 DOI: 10.1158/1055-9965.Epi-10-0674 |
0.43 |
|
| 2010 |
Lerman C. Preclinical data elucidate molecular and neural mechanisms of perinatal nicotine effects on neurodevelopment and behavior: translational opportunities and implications. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 2322-3. PMID 20948511 DOI: 10.1038/Npp.2010.147 |
0.353 |
|
| 2010 |
Perkins KA, Lerman C, Fonte CA, Mercincavage M, Stitzer ML, Chengappa KN, Jain A. Cross-validation of a new procedure for early screening of smoking cessation medications in humans. Clinical Pharmacology and Therapeutics. 88: 109-14. PMID 20485335 DOI: 10.1038/Clpt.2010.65 |
0.484 |
|
| 2010 |
Furberg H, Ostroff J, Lerman C, Sullivan PF. The public health utility of genome-wide association study results for smoking behavior. Genome Medicine. 2: 26. PMID 20423533 DOI: 10.1186/Gm147 |
0.479 |
|
| 2010 |
Rudnick ND, Strasser AA, Phillips JM, Jepson C, Patterson F, Frey JM, Turetsky BI, Lerman C, Siegel SJ. Mouse model predicts effects of smoking and varenicline on event-related potentials in humans. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 589-97. PMID 20395358 DOI: 10.1093/Ntr/Ntq049 |
0.505 |
|
| 2010 |
Wei J, Ma JZ, Payne TJ, Cui W, Ray R, Mitra N, Lerman C, Li MD. Replication and extension of association of choline acetyltransferase with nicotine dependence in European and African American smokers. Human Genetics. 127: 691-8. PMID 20383528 DOI: 10.1007/S00439-010-0818-3 |
0.692 |
|
| 2010 |
Lerman C, Audrain-McGovern J. Reinforcing effects of smoking: more than a feeling. Biological Psychiatry. 67: 699-701. PMID 20362220 DOI: 10.1016/J.Biopsych.2010.02.014 |
0.443 |
|
| 2010 |
Lerman C, Jepson C, Wileyto EP, Patterson F, Schnoll R, Mroziewicz M, Benowitz N, Tyndale RF. Genetic variation in nicotine metabolism predicts the efficacy of extended-duration transdermal nicotine therapy. Clinical Pharmacology and Therapeutics. 87: 553-7. PMID 20336063 DOI: 10.1038/Clpt.2010.3 |
0.399 |
|
| 2010 |
Perkins KA, Mercincavage M, Fonte CA, Lerman C. Varenicline's effects on acute smoking behavior and reward and their association with subsequent abstinence Psychopharmacology. 210: 45-51. PMID 20306175 DOI: 10.1007/S00213-010-1816-9 |
0.475 |
|
| 2010 |
Loughead J, Ray R, Wileyto EP, Ruparel K, Sanborn P, Siegel S, Gur RC, Lerman C. Effects of the alpha4beta2 partial agonist varenicline on brain activity and working memory in abstinent smokers. Biological Psychiatry. 67: 715-21. PMID 20207347 DOI: 10.1016/J.Biopsych.2010.01.016 |
0.734 |
|
| 2010 |
Leader AE, Lerman C, Cappella JN. Nicotine vaccines: will smokers take a shot at quitting? Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 12: 390-7. PMID 20185516 DOI: 10.1093/Ntr/Ntq015 |
0.403 |
|
| 2010 |
Ray R, Mitra N, Baldwin D, Guo M, Patterson F, Heitjan DF, Jepson C, Wileyto EP, Wei J, Payne T, Ma JZ, Li MD, Lerman C. Convergent evidence that choline acetyltransferase gene variation is associated with prospective smoking cessation and nicotine dependence. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 35: 1374-82. PMID 20147892 DOI: 10.1038/Npp.2010.7 |
0.78 |
|
| 2010 |
Schnoll RA, Patterson F, Wileyto EP, Heitjan DF, Shields AE, Asch DA, Lerman C. Effectiveness of extended-duration transdermal nicotine therapy: a randomized trial. Annals of Internal Medicine. 152: 144-51. PMID 20124230 DOI: 10.7326/0003-4819-152-3-201002020-00005 |
0.403 |
|
| 2010 |
Morgan G, Backinger C, Lerman C, Vocci F. Translational medication development for nicotine addiction. American Journal of Health Behavior. 34: 267-74. PMID 20001184 DOI: 10.5993/Ajhb.34.3.2 |
0.354 |
|
| 2010 |
Patterson F, Jepson C, Loughead J, Perkins K, Strasser AA, Siegel S, Frey J, Gur R, Lerman C. Working memory deficits predict short-term smoking resumption following brief abstinence Drug and Alcohol Dependence. 106: 61-64. PMID 19733449 DOI: 10.1016/J.Drugalcdep.2009.07.020 |
0.421 |
|
| 2010 |
Schnoll RA, Lerman C. Abstract PL01-06: Nicotine-dependence pharmacogenetics: Implications for personalized therapy Cancer Prevention Research. 3. DOI: 10.1158/1940-6207.Prev-10-Pl01-06 |
0.513 |
|
| 2009 |
Perkins KA, Lerman C, Mercincavage M, Fonte CA, Briski JL. Nicotinic acetylcholine receptor β2 subunit (CHRNB2) gene and short-term ability to quit smoking in response to nicotine patch Cancer Epidemiology Biomarkers and Prevention. 18: 2608-2612. PMID 19755656 DOI: 10.1158/1055-9965.Epi-09-0166 |
0.516 |
|
| 2009 |
Ray R, Schnoll RA, Lerman C. Nicotine dependence: biology, behavior, and treatment. Annual Review of Medicine. 60: 247-60. PMID 19630572 DOI: 10.1146/Annurev.Med.60.041707.160511 |
0.751 |
|
| 2009 |
Thomas PD, Mi H, Swan GE, Lerman C, Benowitz N, Tyndale RF, Bergen AW, Conti DV. A systems biology network model for genetic association studies of nicotine addiction and treatment. Pharmacogenetics and Genomics. 19: 538-51. PMID 19525886 DOI: 10.1097/Fpc.0B013E32832E2Ced |
0.431 |
|
| 2009 |
Bergen AW, Conti DV, Van Den Berg D, Lee W, Liu J, Li D, Guo N, Mi H, Thomas PD, Lessov-Schlaggar CN, Krasnow R, He Y, Nishita D, Jiang R, McClure JB, ... ... Lerman C, et al. Dopamine genes and nicotine dependence in treatment-seeking and community smokers. Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology. 34: 2252-64. PMID 19494806 DOI: 10.1038/Npp.2009.52 |
0.462 |
|
| 2009 |
Kang Y, Cappella JN, Strasser AA, Lerman C. The effect of smoking cues in antismoking advertisements on smoking urge and psychophysiological reactions. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 254-61. PMID 19251767 DOI: 10.1093/Ntr/Ntn033 |
0.476 |
|
| 2009 |
Strasser AA, Cappella JN, Jepson C, Fishbein M, Tang KZ, Han E, Lerman C. Experimental evaluation of antitobacco PSAs: effects of message content and format on physiological and behavioral outcomes. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 293-302. PMID 19246628 DOI: 10.1093/Ntr/Ntn026 |
0.345 |
|
| 2009 |
Stepanov I, Carmella SG, Han S, Pinto A, Strasser AA, Lerman C, Hecht SS. Evidence for endogenous formation of N'-nitrosonornicotine in some long-term nicotine patch users. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 99-105. PMID 19246447 DOI: 10.1093/Ntr/Ntn004 |
0.377 |
|
| 2009 |
Perkins KA, Briski J, Fonte C, Scott J, Lerman C. Severity of tobacco abstinence symptoms varies by time of day. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 11: 84-91. PMID 19246445 DOI: 10.1093/Ntr/Ntn003 |
0.31 |
|
| 2009 |
Newberg AB, Ray R, Scheuermann J, Wintering N, Saffer J, Schmitz A, Freifelder R, Karp J, Lerman C, Divgi C. Dosimetry of 11C-carfentanil, a micro-opioid receptor imaging agent. Nuclear Medicine Communications. 30: 314-8. PMID 19242386 DOI: 10.1097/Mnm.0B013E328329A0Ec |
0.638 |
|
| 2009 |
Ray R, Tyndale RF, Lerman C. Nicotine dependence pharmacogenetics: role of genetic variation in nicotine-metabolizing enzymes. Journal of Neurogenetics. 23: 252-61. PMID 19169923 DOI: 10.1080/01677060802572887 |
0.77 |
|
| 2009 |
Loughead J, Wileyto EP, Valdez JN, Sanborn P, Tang K, Strasser AA, Ruparel K, Ray R, Gur RC, Lerman C. Effect of abstinence challenge on brain function and cognition in smokers differs by COMT genotype. Molecular Psychiatry. 14: 820-6. PMID 19065145 DOI: 10.1038/Mp.2008.132 |
0.755 |
|
| 2009 |
Schnoll RA, Patterson F, Wileyto EP, Tyndale RF, Benowitz N, Lerman C. Nicotine metabolic rate predicts successful smoking cessation with transdermal nicotine: a validation study. Pharmacology, Biochemistry, and Behavior. 92: 6-11. PMID 19000709 DOI: 10.1016/J.Pbb.2008.10.016 |
0.514 |
|
| 2009 |
Patterson F, Jepson C, Strasser AA, Loughead J, Perkins KA, Gur RC, Frey JM, Siegel S, Lerman C. Varenicline improves mood and cognition during smoking abstinence. Biological Psychiatry. 65: 144-9. PMID 18842256 DOI: 10.1016/J.Biopsych.2008.08.028 |
0.459 |
|
| 2009 |
Perkins KA, Coddington SB, Karelitz JL, Jetton C, Scott JA, Wilson AS, Lerman C. Variability in initial nicotine sensitivity due to sex, history of other drug use, and parental smoking. Drug and Alcohol Dependence. 99: 47-57. PMID 18775605 DOI: 10.1016/J.Drugalcdep.2008.06.017 |
0.504 |
|
| 2008 |
Penning TM, Lerman C. Genomics of smoking exposure and cessation: lessons for cancer prevention and treatment. Cancer Prevention Research (Philadelphia, Pa.). 1: 80-3. PMID 19138939 DOI: 10.1158/1940-6207.Capr-08-0047 |
0.493 |
|
| 2008 |
Furberg H, Lichtenstein P, Pedersen NL, Thornton L, Bulik CM, Lerman C, Sullivan PF. The STAGE cohort: A prospective study of tobacco use among Swedish twins Nicotine and Tobacco Research. 10: 1727-1735. PMID 18988069 DOI: 10.1080/14622200802443551 |
0.424 |
|
| 2008 |
Raybuck JD, Portugal GS, Lerman C, Gould TJ. Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice. Behavioral Neuroscience. 122: 1166-71. PMID 18823172 DOI: 10.1037/A0012601 |
0.468 |
|
| 2008 |
Perkins KA, Lerman C, Grottenthaler A, Ciccocioppo MM, Milanak M, Conklin CA, Bergen AW, Benowitz NL. Dopamine and opioid gene variants are associated with increased smoking reward and reinforcement owing to negative mood. Behavioural Pharmacology. 19: 641-9. PMID 18690118 DOI: 10.1097/Fbp.0B013E32830C367C |
0.526 |
|
| 2008 |
Perkins KA, Lerman C, Coddington S, Jetton C, Karelitz JL, Wilson A, Jennings JR, Ferrell R, Bergen AW, Benowitz NL. Gene and gene by sex associations with initial sensitivity to nicotine in nonsmokers. Behavioural Pharmacology. 19: 630-40. PMID 18690117 DOI: 10.1097/Fbp.0B013E32830C3621 |
0.428 |
|
| 2008 |
Perkins KA, Lerman C, Coddington S, Karelitz JL. Association of retrospective early smoking experiences with prospective sensitivity to nicotine via nasal spray in nonsmokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 10: 1335-45. PMID 18686181 DOI: 10.1080/14622200802238886 |
0.509 |
|
| 2008 |
Furberg H, Lichtenstein P, Pedersen NL, Bulik CM, Lerman C, Sullivan PF. Snus use and other correlates of smoking cessation in the Swedish Twin Registry Psychological Medicine. 38: 1299-1308. PMID 18680625 DOI: 10.1017/S0033291707002346 |
0.464 |
|
| 2008 |
Perkins KA, Lerman C, Coddington SB, Jetton C, Karelitz JL, Scott JA, Wilson AS. Initial nicotine sensitivity in humans as a function of impulsivity. Psychopharmacology. 200: 529-44. PMID 18604520 DOI: 10.1007/S00213-008-1231-7 |
0.482 |
|
| 2008 |
Ray R, Loughead J, Wang Z, Detre J, Yang E, Gur R, Lerman C. Neuroimaging, genetics and the treatment of nicotine addiction Behavioural Brain Research. 193: 159-169. PMID 18599130 DOI: 10.1016/J.Bbr.2008.05.021 |
0.737 |
|
| 2008 |
Conti DV, Lee W, Li D, Liu J, Van Den Berg D, Thomas PD, Bergen AW, Swan GE, Tyndale RF, Benowitz NL, Lerman C. Nicotinic acetylcholine receptor beta2 subunit gene implicated in a systems-based candidate gene study of smoking cessation. Human Molecular Genetics. 17: 2834-48. PMID 18593715 DOI: 10.1093/Hmg/Ddn181 |
0.46 |
|
| 2008 |
Shields AE, Levy DE, Blumenthal D, Currivan D, McGinn-Shapiro M, Weiss KB, Yucel R, Lerman C. Primary care physicians' willingness to offer a new genetic test to tailor smoking treatment, according to test characteristics. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 10: 1037-45. PMID 18584467 DOI: 10.1080/14622200802087580 |
0.435 |
|
| 2008 |
Piper ME, McCarthy DE, Bolt DM, Smith SS, Lerman C, Benowitz N, Fiore MC, Baker TB. Assessing dimensions of nicotine dependence: an evaluation of the Nicotine Dependence Syndrome Scale (NDSS) and the Wisconsin Inventory of Smoking Dependence Motives (WISDM). Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 10: 1009-20. PMID 18584464 DOI: 10.1080/14622200802097563 |
0.536 |
|
| 2008 |
David SP, Johnstone EC, Murphy MF, Aveyard P, Guo B, Lerman C, Munafò MR. Genetic variation in the serotonin pathway and smoking cessation with nicotine replacement therapy: new data from the Patch in Practice trial and pooled analyses. Drug and Alcohol Dependence. 98: 77-85. PMID 18562131 DOI: 10.1016/J.Drugalcdep.2008.04.013 |
0.414 |
|
| 2008 |
Schnoll RA, Wileyto EP, Pinto A, Leone F, Gariti P, Siegel S, Perkins KA, Dackis C, Heitjan DF, Berrettini W, Lerman C. A placebo-controlled trial of modafinil for nicotine dependence. Drug and Alcohol Dependence. 98: 86-93. PMID 18541389 DOI: 10.1016/J.Drugalcdep.2008.04.008 |
0.517 |
|
| 2008 |
Uhl GR, Liu QR, Drgon T, Johnson C, Walther D, Rose JE, David SP, Niaura R, Lerman C. Molecular genetics of successful smoking cessation: convergent genome-wide association study results. Archives of General Psychiatry. 65: 683-93. PMID 18519826 DOI: 10.1001/Archpsyc.65.6.683 |
0.492 |
|
| 2008 |
Ray R, Rukstalis M, Jepson C, Strasser A, Patterson F, Lynch K, Lerman C. Effects of atomoxetine on subjective and neurocognitive symptoms of nicotine abstinence. Journal of Psychopharmacology (Oxford, England). 23: 168-76. PMID 18515446 DOI: 10.1177/0269881108089580 |
0.76 |
|
| 2008 |
Wang Z, Ray R, Faith M, Tang K, Wileyto EP, Detre JA, Lerman C. Nicotine abstinence-induced cerebral blood flow changes by genotype. Neuroscience Letters. 438: 275-80. PMID 18499348 DOI: 10.1016/J.Neulet.2008.04.084 |
0.75 |
|
| 2008 |
Perkins KA, Lerman C, Stitzer M, Fonte CA, Briski JL, Scott JA, Chengappa KN. Development of procedures for early screening of smoking cessation medications in humans. Clinical Pharmacology and Therapeutics. 84: 216-21. PMID 18388880 DOI: 10.1038/Clpt.2008.30 |
0.519 |
|
| 2008 |
Patterson F, Schnoll RA, Wileyto EP, Pinto A, Epstein LH, Shields PG, Hawk LW, Tyndale RF, Benowitz N, Lerman C. Toward personalized therapy for smoking cessation: a randomized placebo-controlled trial of bupropion. Clinical Pharmacology and Therapeutics. 84: 320-5. PMID 18388868 DOI: 10.1038/Clpt.2008.57 |
0.491 |
|
| 2008 |
Heitjan DF, Asch DA, Ray R, Rukstalis M, Patterson F, Lerman C. Cost-effectiveness of pharmacogenetic testing to tailor smoking-cessation treatment Pharmacogenomics Journal. 8: 391-399. PMID 18347612 DOI: 10.1038/Sj.Tpj.6500492 |
0.737 |
|
| 2008 |
Patterson F, Kerrin K, Wileyto EP, Lerman C. Increase in anger symptoms after smoking cessation predicts relapse. Drug and Alcohol Dependence. 95: 173-6. PMID 18328642 DOI: 10.1016/J.Drugalcdep.2008.01.013 |
0.485 |
|
| 2008 |
Shields A, Lerman C. Anticipating Clinical Integration of Pharmacogenetic Treatment Strategies for Addiction: Are Primary Care Physicians Ready? Clinical Pharmacology & Therapeutics. 83: 635-639. PMID 18323859 DOI: 10.1038/Clpt.2008.4 |
0.316 |
|
| 2008 |
Heitjan DF, Guo M, Ray R, Wileyto EP, Epstein LH, Lerman C. Identification of pharmacogenetic markers in smoking cessation therapy. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 147: 712-9. PMID 18165968 DOI: 10.1002/Ajmg.B.30669 |
0.707 |
|
| 2008 |
Schnoll RA, Epstein L, Audrain J, Niaura R, Hawk L, Shields PG, Lerman C, Wileyto EP. Can the blind see? Participant guess about treatment arm assignment may influence outcome in a clinical trial of bupropion for smoking cessation. Journal of Substance Abuse Treatment. 34: 234-41. PMID 17600649 DOI: 10.1016/J.Jsat.2007.04.004 |
0.433 |
|
| 2007 |
Wang Z, Faith M, Patterson F, Tang K, Kerrin K, Wileyto EP, Detre JA, Lerman C. Neural substrates of abstinence-induced cigarette cravings in chronic smokers. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 27: 14035-40. PMID 18094242 DOI: 10.1523/Jneurosci.2966-07.2007 |
0.476 |
|
| 2007 |
Phillips JM, Siegel SJ, Shields AE, Patterson F, Gould TJ, Strasser AA, Ray R, Pinto A, Audrain-McGovern J, Rukstalis M, Perkins KA, Blendy JA, Lerman C. Translating basic science to improve pharmacotherapy for nicotine dependence. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: S583-98. PMID 18067034 DOI: 10.1080/14622200701691755 |
0.713 |
|
| 2007 |
David SP, Strong DR, Munafò MR, Brown RA, Lloyd-Richardson EE, Wileyto PE, Evins EA, Shields PG, Lerman C, Niaura R. Bupropion efficacy for smoking cessation is influenced by the DRD2 Taq1A polymorphism: analysis of pooled data from two clinical trials. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 1251-7. PMID 18058343 DOI: 10.1080/14622200701705027 |
0.395 |
|
| 2007 |
Lerman CE, Schnoll RA, Munafò MR. Genetics and smoking cessation improving outcomes in smokers at risk. American Journal of Preventive Medicine. 33: S398-405. PMID 18021915 DOI: 10.1016/j.amepre.2007.09.006 |
0.453 |
|
| 2007 |
Ray R, Jepson C, Wileyto EP, Dahl JP, Patterson F, Rukstalis M, Pinto A, Berrettini W, Lerman C. Genetic variation in mu-opioid-receptor-interacting proteins and smoking cessation in a nicotine replacement therapy trial. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 1237-41. PMID 17978999 DOI: 10.1080/14622200701648367 |
0.737 |
|
| 2007 |
Schnoll RA, Patterson F, Lerman C. Treating tobacco dependence in women. Journal of Women's Health (2002). 16: 1211-8. PMID 17937574 DOI: 10.1089/Jwh.2006.0281 |
0.416 |
|
| 2007 |
Schnoll RA, Johnson TA, Lerman C. Genetics and smoking behavior. Current Psychiatry Reports. 9: 349-57. PMID 17915073 DOI: 10.1007/S11920-007-0045-3 |
0.491 |
|
| 2007 |
Hutchison KE, Allen DL, Filbey FM, Jepson C, Lerman C, Benowitz NL, Stitzel J, Bryan A, McGeary J, Haughey HM. CHRNA4 and tobacco dependence: from gene regulation to treatment outcome. Archives of General Psychiatry. 64: 1078-86. PMID 17768273 DOI: 10.1001/Archpsyc.64.9.1078 |
0.503 |
|
| 2007 |
Lerman C, LeSage MG, Perkins KA, O'Malley SS, Siegel SJ, Benowitz NL, Corrigall WA. Translational research in medication development for nicotine dependence. Nature Reviews. Drug Discovery. 6: 746-62. PMID 17690709 DOI: 10.1038/Nrd2361 |
0.343 |
|
| 2007 |
David SP, Brown RA, Papandonatos GD, Kahler CW, Lloyd-Richardson EE, Munafò MR, Shields PG, Lerman C, Strong D, McCaffery J, Niaura R. Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 821-33. PMID 17654295 DOI: 10.1080/14622200701382033 |
0.429 |
|
| 2007 |
Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Heishman SJ, Lerman C, Pickworth WB. Associations between Cloninger's temperament dimensions and acute tobacco withdrawal. Addictive Behaviors. 32: 2976-89. PMID 17624682 DOI: 10.1016/J.Addbeh.2007.06.014 |
0.519 |
|
| 2007 |
Waters AJ, Heishman SJ, Lerman C, Pickworth W. Enhanced identification of smoking-related words during the attentional blink in smokers. Addictive Behaviors. 32: 3077-82. PMID 17616446 DOI: 10.1016/J.Addbeh.2007.05.016 |
0.401 |
|
| 2007 |
Ray R, Jepson C, Wileyto P, Patterson F, Strasser AA, Rukstalis M, Perkins K, Blendy J, Lerman C. CREB1 haplotypes and the relative reinforcing value of nicotine. Molecular Psychiatry. 12: 615-7. PMID 17592483 DOI: 10.1038/Sj.Mp.4002002 |
0.709 |
|
| 2007 |
Ray R, Schnoll RA, Lerman C. Pharmacogenetics and smoking cessation with nicotine replacement therapy. Cns Drugs. 21: 525-33. PMID 17579497 DOI: 10.2165/00023210-200721070-00001 |
0.77 |
|
| 2007 |
Lee AM, Jepson C, Shields PG, Benowitz N, Lerman C, Tyndale RF. CYP2B6 genotype does not alter nicotine metabolism, plasma levels, or abstinence with nicotine replacement therapy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 16: 1312-4. PMID 17548706 DOI: 10.1158/1055-9965.Epi-07-0188 |
0.392 |
|
| 2007 |
Newberg A, Lerman C, Wintering N, Ploessl K, Mozley PD. Dopamine transporter binding in smokers and nonsmokers. Clinical Nuclear Medicine. 32: 452-455. PMID 17515751 DOI: 10.1097/01.Rlu.0000262980.98342.Dd |
0.4 |
|
| 2007 |
Strasser AA, Malaiyandi V, Hoffmann E, Tyndale RF, Lerman C. An association of CYP2A6 genotype and smoking topography. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 9: 511-8. PMID 17454707 DOI: 10.1080/14622200701239605 |
0.51 |
|
| 2007 |
Leventhal AM, Waters AJ, Boyd S, Moolchan ET, Lerman C, Pickworth WB. Gender differences in acute tobacco withdrawal: effects on subjective, cognitive, and physiological measures. Experimental and Clinical Psychopharmacology. 15: 21-36. PMID 17295582 DOI: 10.1037/1064-1297.15.1.21 |
0.487 |
|
| 2007 |
Lee AM, Jepson C, Hoffmann E, Epstein L, Hawk LW, Lerman C, Tyndale RF. CYP2B6 genotype alters abstinence rates in a bupropion smoking cessation trial. Biological Psychiatry. 62: 635-41. PMID 17223085 DOI: 10.1016/J.Biopsych.2006.10.005 |
0.451 |
|
| 2007 |
Strasser AA, Lerman C, Sanborn PM, Pickworth WB, Feldman EA. New lower nicotine cigarettes can produce compensatory smoking and increased carbon monoxide exposure Drug and Alcohol Dependence. 86: 294-300. PMID 16930853 DOI: 10.1016/J.Drugalcdep.2006.06.017 |
0.53 |
|
| 2007 |
Berrettini WH, Wileyto EP, Epstein L, Restine S, Hawk L, Shields P, Niaura R, Lerman C. Catechol-O-Methyltransferase (COMT) Gene Variants Predict Response to Bupropion Therapy for Tobacco Dependence Biological Psychiatry. 61: 111-118. PMID 16876132 DOI: 10.1016/J.Biopsych.2006.04.030 |
0.466 |
|
| 2007 |
David SP, Brown RA, Papandonatos GD, Kahler CW, Lloyd-Richardson EE, Munafò MR, Shields PG, Lerman C, Strong D, McCaffery J, Niura R. Erratum: Pharmacogenetic clinical trial of sustained-release bupropion for smoking cessation (Nicotine and Tobacco Research (2007) vol. 9 (8) (821-833)) Nicotine & Tobacco Research. 9. DOI: 10.1080/14622200701773611 |
0.496 |
|
| 2006 |
Strasser AA, Lerman C, Cappella JN. Lower nicotine cigarettes may not lower harm. Ldi Issue Brief. 12: 1-4. PMID 17302017 |
0.421 |
|
| 2006 |
Munafò M, Lerman C. Can pharmacogenetics help smokers quit Pharmacogenomics. 7: 1137-1140. PMID 17184199 DOI: 10.2217/14622416.7.8.1137 |
0.536 |
|
| 2006 |
Hu J, Redden DT, Berrettini WH, Shields PG, Restine SL, Pinto A, Lerman C, Allison DB. No evidence for a major role of polymorphisms during bupropion treatment. Obesity (Silver Spring, Md.). 14: 1863-7. PMID 17135598 DOI: 10.1038/Oby.2006.215 |
0.4 |
|
| 2006 |
Ray R, Jepson C, Patterson F, Strasser A, Rukstalis M, Perkins K, Lynch KG, O'Malley S, Berrettini WH, Lerman C. Association of OPRM1 A118G variant with the relative reinforcing value of nicotine. Psychopharmacology. 188: 355-63. PMID 16960700 DOI: 10.1007/S00213-006-0504-2 |
0.713 |
|
| 2006 |
Schnoll RA, Lerman C. Current and emerging pharmacotherapies for treating tobacco dependence. Expert Opinion On Emerging Drugs. 11: 429-444. PMID 16939383 DOI: 10.1517/14728214.11.3.429 |
0.517 |
|
| 2006 |
Lerman C. Helping smokers quit through pharmacogenetics. Ldi Issue Brief. 11: 1-4. PMID 16827222 |
0.423 |
|
| 2006 |
Lerman C, Tyndale R, Patterson F, Wileyto EP, Shields PG, Pinto A, Benowitz N. Nicotine metabolite ratio predicts efficacy of transdermal nicotine for smoking cessation. Clinical Pharmacology and Therapeutics. 79: 600-8. PMID 16765148 DOI: 10.1016/J.Clpt.2006.02.006 |
0.505 |
|
| 2006 |
Shadel WG, Lerman C, Cappella J, Strasser AA, Pinto A, Hornik R. Evaluating smokers' reactions to advertising for new lower nicotine quest cigarettes. Psychology of Addictive Behaviors : Journal of the Society of Psychologists in Addictive Behaviors. 20: 80-4. PMID 16536669 DOI: 10.1037/0893-164X.20.1.80 |
0.506 |
|
| 2006 |
Munafò MR, Johnstone EC, Wileyto EP, Shields PG, Elliot KM, Lerman C. Lack of association of 5-HTTLPR genotype with smoking cessation in a nicotine replacement therapy randomized trial. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 398-400. PMID 16492936 DOI: 10.1158/1055-9965.Epi-05-0648 |
0.475 |
|
| 2006 |
Volpp KG, Gurmankin Levy A, Asch DA, Berlin JA, Murphy JJ, Gomez A, Sox H, Zhu J, Lerman C. A randomized controlled trial of financial incentives for smoking cessation. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 15: 12-8. PMID 16434580 DOI: 10.1158/1055-9965.Epi-05-0314 |
0.372 |
|
| 2006 |
Malaiyandi V, Lerman C, Benowitz NL, Jepson C, Patterson F, Tyndale RF. Impact of CYP2A6 genotype on pretreatment smoking behaviour and nicotine levels from and usage of nicotine replacement therapy. Molecular Psychiatry. 11: 400-9. PMID 16402128 DOI: 10.1038/Sj.Mp.4001794 |
0.485 |
|
| 2006 |
Dahl JP, Jepson C, Levenson R, Wileyto EP, Patterson F, Berrettini WH, Lerman C. Interaction between variation in the D2 dopamine receptor (DRD2) and the neuronal calcium sensor-1 (FREQ) genes in predicting response to nicotine replacement therapy for tobacco dependence. The Pharmacogenomics Journal. 6: 194-9. PMID 16402081 DOI: 10.1038/Sj.Tpj.6500358 |
0.394 |
|
| 2006 |
Furberg H, Bulik CM, Lerman C, Lichtenstein P, Pedersen NL, Sullivan PF. Is Swedish snus associated with smoking initiation or smoking cessation? Tobacco Control. 14: 422-4. PMID 16319367 DOI: 10.1136/Tc.2005.012476 |
0.532 |
|
| 2006 |
Perkins KA, Stitzer M, Lerman C. Medication screening for smoking cessation: a proposal for new methodologies. Psychopharmacology. 184: 628-36. PMID 16163529 DOI: 10.1007/S00213-005-0105-5 |
0.331 |
|
| 2006 |
Lerman C, Jepson C, Wileyto EP, Epstein LH, Rukstalis M, Patterson F, Kaufmann V, Restine S, Hawk L, Niaura R, Berrettini W. Role of functional genetic variation in the dopamine D2 receptor (DRD2) in response to bupropion and nicotine replacement therapy for tobacco dependence: Results of two randomized clinical trials Neuropsychopharmacology. 31: 231-242. PMID 16123753 DOI: 10.1038/Sj.Npp.1300861 |
0.451 |
|
| 2005 |
Schnoll RA, Rothman RL, Wielt DB, Lerman C, Pedri H, Wang H, Babb J, Miller SM, Movsas B, Sherman E, Ridge JA, Unger M, Langer C, Goldberg M, Scott W, et al. A randomized pilot study of cognitive-behavioral therapy versus basic health education for smoking cessation among cancer patients. Annals of Behavioral Medicine : a Publication of the Society of Behavioral Medicine. 30: 1-11. PMID 16097900 DOI: 10.1207/S15324796Abm3001_1 |
0.486 |
|
| 2005 |
Furberg H, Sullivan PF, Maes H, Prescott CA, Lerman C, Bulik C, Kendler KS. The types of regular cigarette smokers: a latent class analysis. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 7: 351-60. PMID 16085503 DOI: 10.1080/14622200500124917 |
0.515 |
|
| 2005 |
Berrettini WH, Lerman CE. Pharmacotherapy and pharmacogenetics of nicotine dependence. The American Journal of Psychiatry. 162: 1441-51. PMID 16055765 DOI: 10.1176/APPI.AJP.162.8.1441 |
0.363 |
|
| 2005 |
Wileyto EP, Patterson F, Niaura R, Epstein LH, Brown RA, Audrain-McGovern J, Hawk LW, Lerman C. Recurrent event analysis of lapse and recovery in a smoking cessation clinical trial using bupropion. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 7: 257-68. PMID 16036283 DOI: 10.1080/14622200500055673 |
0.379 |
|
| 2005 |
Munafò MR, Shields AE, Berrettini WH, Patterson F, Lerman C. Pharmacogenetics and nicotine addiction treatment. Pharmacogenomics. 6: 211-23. PMID 16013953 DOI: 10.1517/14622416.6.3.211 |
0.5 |
|
| 2005 |
Munafò MR, Lerman C, Niaura R, Shields AE, Swan GE. Smoking cessation treatment: pharmacogenetic assessment. Current Opinion in Molecular Therapeutics. 7: 202-8. PMID 15977416 |
0.315 |
|
| 2005 |
Redden DT, Shields PG, Epstein L, Wileyto EP, Zakharkin SO, Allison DB, Lerman C. Catechol-O-methyl-transferase functional polymorphism and nicotine dependence: an evaluation of nonreplicated results. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 14: 1384-9. PMID 15941945 DOI: 10.1158/1055-9965.Epi-04-0649 |
0.44 |
|
| 2005 |
Rukstalis M, Jepson C, Patterson F, Lerman C. Increases in hyperactive-impulsive symptoms predict relapse among smokers in nicotine replacement therapy. Journal of Substance Abuse Treatment. 28: 297-304. PMID 15925263 DOI: 10.1016/J.Jsat.2005.02.002 |
0.412 |
|
| 2005 |
Siegel SJ, Maxwell CR, Majumdar S, Trief DF, Lerman C, Gur RE, Kanes SJ, Liang Y. Monoamine reuptake inhibition and nicotine receptor antagonism reduce amplitude and gating of auditory evoked potentials. Neuroscience. 133: 729-38. PMID 15908134 DOI: 10.1016/J.Neuroscience.2005.03.027 |
0.346 |
|
| 2005 |
Colilla S, Lerman C, Shields PG, Jepson C, Rukstalis M, Berlin J, DeMichele A, Bunin G, Strom BL, Rebbeck TR. Association of catechol-O-methyltransferase with smoking cessation in two independent studies of women. Pharmacogenetics and Genomics. 15: 393-8. PMID 15900212 DOI: 10.1097/01213011-200506000-00004 |
0.468 |
|
| 2005 |
Shields AE, Blumenthal D, Weiss KB, Comstock CB, Currivan D, Lerman C. Barriers to translating emerging genetic research on smoking into clinical practice. Perspectives of primary care physicians. Journal of General Internal Medicine. 20: 131-8. PMID 15836545 DOI: 10.1111/J.1525-1497.2005.30429.X |
0.457 |
|
| 2005 |
Blendy JA, Strasser A, Walters CL, Perkins KA, Patterson F, Berkowitz R, Lerman C. Reduced nicotine reward in obesity: cross-comparison in human and mouse. Psychopharmacology. 180: 306-15. PMID 15719224 DOI: 10.1007/S00213-005-2167-9 |
0.393 |
|
| 2005 |
Rukstalis M, Jepson C, Strasser A, Lynch KG, Perkins K, Patterson F, Lerman C. Naltrexone reduces the relative reinforcing value of nicotine in a cigarette smoking choice paradigm. Psychopharmacology. 180: 41-8. PMID 15682300 DOI: 10.1007/S00213-004-2136-8 |
0.51 |
|
| 2005 |
Shields AE, Fortun M, Hammonds EM, King PA, Lerman C, Rapp R, Sullivan PF. The use of race variables in genetic studies of complex traits and the goal of reducing health disparities: a transdisciplinary perspective. The American Psychologist. 60: 77-103. PMID 15641924 DOI: 10.1037/0003-066X.60.1.77 |
0.301 |
|
| 2005 |
Lerman C, Patterson F, Berrettini W. Treating tobacco dependence: state of the science and new directions. Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. 23: 311-23. PMID 15637394 DOI: 10.1200/Jco.2005.04.058 |
0.493 |
|
| 2005 |
Strasser AA, Kaufmann V, Jepson C, Perkins KA, Pickworth WB, Wileyto EP, Rukstalis M, Audrain-McGovern J, Lerman C. Effects of different nicotine replacement therapies on postcessation psychological responses. Addictive Behaviors. 30: 9-17. PMID 15561445 DOI: 10.1016/J.Addbeh.2004.04.005 |
0.408 |
|
| 2005 |
Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH. Effects of dopamine D2 receptor (DRD2) and transporter (SLC6A3) polymorphisms on smoking cue-induced cigarette craving among African-American smokers. Molecular Psychiatry. 10: 407-14. PMID 15381926 DOI: 10.1038/Sj.Mp.4001588 |
0.46 |
|
| 2005 |
Cappella JN, Lerman C, Romantan A, Baruh L. News about genetics and smoking: Priming, family smoking history, and news story believability on inferences of genetic susceptibility to tobacco addiction Communication Research. 32: 478-502. DOI: 10.1177/0093650205277320 |
0.49 |
|
| 2004 |
Lerman C, Niaura R, Collins BN, Wileyto P, Audrain-McGovern J, Pinto A, Hawk L, Epstein LH. Effect of bupropion on depression symptoms in a smoking cessation clinical trial Psychology of Addictive Behaviors. 18: 362-366. PMID 15631608 DOI: 10.1037/0893-164X.18.4.362 |
0.372 |
|
| 2004 |
Strasser AA, Pickworth WB, Patterson F, Lerman C. Smoking topography predicts abstinence following treatment with nicotine replacement therapy. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 13: 1800-4. PMID 15533910 |
0.42 |
|
| 2004 |
Shields AE, Lerman C, Sullivan PF. Translating emerging research on the genetics of smoking into clinical practice: ethical and social considerations. Nicotine & Tobacco Research. 6: 675-688. PMID 15370164 DOI: 10.1080/14622200410001734058 |
0.476 |
|
| 2004 |
Jaroni JL, Wright SM, Lerman C, Epstein LH. Relationship between education and delay discounting in smokers. Addictive Behaviors. 29: 1171-5. PMID 15236819 DOI: 10.1016/J.Addbeh.2004.03.014 |
0.356 |
|
| 2004 |
Audrain-McGovern J, Lerman C, Wileyto EP, Rodriguez D, Shields PG. Interacting effects of genetic predisposition and depression on adolescent smoking progression. The American Journal of Psychiatry. 161: 1224-30. PMID 15229055 DOI: 10.1176/Appi.Ajp.161.7.1224 |
0.449 |
|
| 2004 |
Wileyto EP, Patterson F, Niaura R, Epstein LH, Brown RA, Audrain-McGovern J, Hawk LW, Lerman C. Do small lapses predict relapse to smoking behavior under bupropion treatment? Nicotine and Tobacco Research. 6: 357-367. PMID 15203809 DOI: 10.1080/1462220042000202463 |
0.412 |
|
| 2004 |
Perkins KA, Lerman C, Keenan J, Fonte C, Coddington S. Rate of nicotine onset from nicotine replacement therapy and acute responses in smokers. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 6: 501-7. PMID 15203784 DOI: 10.1080/14622200410001696547 |
0.49 |
|
| 2004 |
Lerman C, Berrettini W, Pinto A, Patterson F, Crystal-Mansour S, Wileyto EP, Restine SL, Leonard DGB, Shields PG, Epstein LH. Changes in food reward following smoking cessation: A pharmacogenetic investigation Psychopharmacology. 174: 571-577. PMID 15138759 DOI: 10.1007/S00213-004-1823-9 |
0.432 |
|
| 2004 |
Schnoll RA, Rothman RL, Newman H, Lerman C, Miller SM, Movsas B, Sherman E, Ridge JA, Unger M, Langer C, Goldberg M, Scott W, Cheng J. Characteristics of cancer patients entering a smoking cessation program and correlates of quit motivation: implications for the development of tobacco control programs for cancer patients. Psycho-Oncology. 13: 346-58. PMID 15133775 DOI: 10.1002/Pon.756 |
0.503 |
|
| 2004 |
Patterson F, Lerman C, Kaufmann VG, Neuner GA, Audrain-McGovern J. Cigarette smoking practices among American college students: review and future directions. Journal of American College Health : J of Ach. 52: 203-10. PMID 15029942 DOI: 10.3200/Jach.52.5.203-212 |
0.456 |
|
| 2004 |
Lerman C, Kaufmann V, Rukstalis M, Patterson F, Perkins K, Audrain-McGovern J, Benowitz N. Individualizing nicotine replacement therapy for the treatment of tobacco dependence: a randomized trial. Annals of Internal Medicine. 140: 426-33. PMID 15023708 DOI: 10.7326/0003-4819-140-6-200403160-00009 |
0.423 |
|
| 2004 |
Lerman C, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Restine S, Shields PG, Kaufmann V, Redden D, Benowitz N, Berrettini WH. The functional mu opioid receptor (OPRM1) Asn40Asp variant predicts short-term response to nicotine replacement therapy in a clinical trial Pharmacogenomics Journal. 4: 184-192. PMID 15007373 DOI: 10.1038/Sj.Tpj.6500238 |
0.429 |
|
| 2004 |
Schnoll RA, Rothman RL, Lerman C, Miller SM, Newman H, Movsas B, Sherman E, Ridge JA, Unger M, Langer C, Goldberg M, Scott W, Cheng J. Comparing cancer patients who enroll in a smoking cessation program at a comprehensive cancer center with those who decline enrollment. Head & Neck. 26: 278-86. PMID 14999804 DOI: 10.1002/Hed.10368 |
0.44 |
|
| 2004 |
Collins BN, Wileyto EP, Patterson F, Rukstalis M, Audrain-McGovern J, Kaufmann V, Pinto A, Hawk L, Niaura R, Epstein LH, Lerman C. Gender differences in smoking cessation in a placebo-controlled trial of bupropion with behavioral counseling Nicotine and Tobacco Research. 6: 27-37. PMID 14982685 DOI: 10.1080/14622200310001656830 |
0.483 |
|
| 2004 |
Erblich J, Lerman C, Self DW, Diaz GA, Bovbjerg DH. Stress-induced cigarette craving: effects of the DRD2 TaqI RFLP and SLC6A3 VNTR polymorphisms. The Pharmacogenomics Journal. 4: 102-9. PMID 14732864 DOI: 10.1038/Sj.Tpj.6500227 |
0.378 |
|
| 2003 |
Baker TB, Hatsukami DK, Lerman C, O'Malley SS, Shields AE, Fiore MC. Transdisciplinary science applied to the evaluation of treatments for tobacco use Nicotine and Tobacco Research. 5. PMID 14668089 DOI: 10.1080/14622200310001625564 |
0.313 |
|
| 2003 |
Shenassa ED, McCaffery JM, Swan GE, Khroyan TV, Shakib S, Lerman C, Lyons M, Mouttapa M, Niaura RS, Buka SL, Leslie F, Santangelo SL. Intergenerational transmission of tobacco use and dependence: a transdisciplinary perspective. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 5: S55-69. PMID 14668087 DOI: 10.1080/14622200310001625500 |
0.478 |
|
| 2003 |
Morgan GD, Kobus K, Gerlach KK, Neighbors C, Lerman C, Abrams DB, Rimer BK. Facilitating transdisciplinary research: the experience of the transdisciplinary tobacco use research centers. Nicotine & Tobacco Research. 5: 11-19. PMID 14668084 DOI: 10.1080/14622200310001625537 |
0.349 |
|
| 2003 |
Kaufmann V, Jepson C, Rukstalis M, Perkins K, Audrain-McGovern J, Lerman C. Subjective effects of an initial dose of nicotine nasal spray predict treatment outcome. Psychopharmacology. 172: 271-6. PMID 14647969 DOI: 10.1007/S00213-003-1659-8 |
0.484 |
|
| 2003 |
Patterson F, Jepson C, Kaufmann V, Rukstalis M, Audrain-McGovern J, Kucharski S, Lerman C. Predictors of attendance in a randomized clinical trial of nicotine replacement therapy with behavioral counseling. Drug and Alcohol Dependence. 72: 123-31. PMID 14636967 DOI: 10.1016/S0376-8716(03)00194-7 |
0.503 |
|
| 2003 |
Lerman C, Wileyto EP, Audrain J, Pinto A, Kucharski S, Niaura R, Shields PG, Hawk LH, Krishnan S, Epstein LH. Effects of dopamine transporter and receptor polymorphisms on smoking cessation in a bupropion clinical trial Health Psychology. 22: 541-548. PMID 14570538 DOI: 10.1037/0278-6133.22.5.541 |
0.482 |
|
| 2003 |
Audrain-McGovern J, Tercyak KP, Shields AE, Bush A, Espinel CF, Lerman C. Which Adolescents Are Most Receptive to Tobacco Industry Marketing? Implications for Counter-Advertising Campaigns Health Communication. 15: 499-513. PMID 14527869 DOI: 10.1207/S15327027Hc1504_07 |
0.429 |
|
| 2003 |
Kaufmann V, Lerman C. Genes, smoking, and treatment response American Journal of Health-System Pharmacy. 60: 1911-1911. PMID 14521049 DOI: 10.1093/Ajhp/60.18.1911 |
0.443 |
|
| 2003 |
Miksys S, Lerman C, Shields PG, Mash DC, Tyndale RF. Smoking, alcoholism and genetic polymorphisms alter CYP2B6 levels in human brain. Neuropharmacology. 45: 122-32. PMID 12814665 DOI: 10.1016/S0028-3908(03)00136-9 |
0.407 |
|
| 2003 |
Epstein LH, Richards JB, Saad FG, Paluch RA, Roemmich JN, Lerman C. Comparison between two measures of delay discounting in smokers. Experimental and Clinical Psychopharmacology. 11: 131-8. PMID 12755457 DOI: 10.1037/1064-1297.11.2.131 |
0.302 |
|
| 2003 |
Patterson F, Benowitz N, Shields P, Kaufmann V, Jepson C, Wileyto P, Kucharski S, Lerman C. Individual differences in nicotine intake per cigarette. Cancer Epidemiology, Biomarkers & Prevention : a Publication of the American Association For Cancer Research, Cosponsored by the American Society of Preventive Oncology. 12: 468-71. PMID 12750245 |
0.442 |
|
| 2003 |
Lerman C, Berrettini W. Elucidating the role of genetic factors in smoking behavior and nicotine dependence. American Journal of Medical Genetics. Part B, Neuropsychiatric Genetics : the Official Publication of the International Society of Psychiatric Genetics. 48-54. PMID 12627466 DOI: 10.1002/Ajmg.B.10003 |
0.512 |
|
| 2003 |
Miksys S, Lerman C, Shields P, Mash D, Tyndale R. The influence of smoking, alcoholism and genetics on CYP2B6 in human brain Clinical Pharmacology & Therapeutics. 73: P59-P59. DOI: 10.1016/S0009-9236(03)90576-5 |
0.392 |
|
| 2002 |
Epstein LH, Jaroni JL, Paluch RA, Leddy JJ, Vahue HE, Hawk L, Wileyto EP, Shields PG, Lerman C. Dopamine transporter genotype as a risk factor for obesity in African-American smokers. Obesity Research. 10: 1232-40. PMID 12490667 DOI: 10.1038/Oby.2002.168 |
0.336 |
|
| 2002 |
Lerman C, Shields PG, Wileyto EP, Audrain J, Pinto A, Hawk L, Krishnan S, Niaura R, Epstein L. Pharmacogenetic investigation of smoking cessation treatment Pharmacogenetics. 12: 627-634. PMID 12439223 DOI: 10.1097/00008571-200211000-00007 |
0.528 |
|
| 2002 |
Lerman C, Niaura R. Applying genetic approaches to the treatment of nicotine dependence. Oncogene. 21: 7412-7420. PMID 12379882 DOI: 10.1038/Sj.Onc.1205801 |
0.508 |
|
| 2002 |
Tercyak KP, Lerman C, Audrain J. Association of attention-deficit/hyperactivity disorder symptoms with levels of cigarette smoking in a community sample of adolescents. Journal of the American Academy of Child and Adolescent Psychiatry. 41: 799-805. PMID 12108804 DOI: 10.1097/00004583-200207000-00011 |
0.479 |
|
| 2002 |
Lerman C, Roth D, Kaufmann V, Audrain J, Hawk L, Liu A, Niaura R, Epstein L. Mediating mechanisms for the impact of bupropion in smoking cessation treatment Drug and Alcohol Dependence. 67: 219-223. PMID 12095672 DOI: 10.1016/S0376-8716(02)00067-4 |
0.447 |
|
| 2001 |
Lerman C, Audrain J, Tercyak K, Hawk LW, Bush A, Crystal-Mansour S, Rose C, Niaura R, Epstein LH. Attention-Deficit Hyperactivity Disorder (ADHD) symptoms and smoking patterns among participants in a smoking-cessation program. Nicotine & Tobacco Research : Official Journal of the Society For Research On Nicotine and Tobacco. 3: 353-9. PMID 11694203 DOI: 10.1080/14622200110072156 |
0.457 |
|
| 2001 |
Lerman C, Caporaso NE, Bush A, Zheng YL, Audrain J, Main D, Shields PG. Tryptophan hydroxylase gene variant and smoking behavior American Journal of Medical Genetics - Neuropsychiatric Genetics. 105: 518-520. PMID 11496367 DOI: 10.1002/Ajmg.1476 |
0.506 |
|
| 2001 |
Marteau TM, Lerman C. Genetic risk and behavioural change Bmj. 322: 1056-1059. PMID 11325776 DOI: 10.1136/Bmj.322.7293.1056 |
0.303 |
|
| 2000 |
Lerman C, Caporaso NE, Audrain J, Main D, Boyd NR, Shields PG. Interacting effects of the serotonin transporter gene and neuroticism in smoking practices and nicotine dependence Molecular Psychiatry. 5: 189-192. PMID 10822347 DOI: 10.1038/Sj.Mp.4000672 |
0.509 |
|
| 1999 |
Lerman C, Caporaso NE, Audrain J, Main D, Bowman ED, Lockshin B, Boyd NR, Shields PG. Evidence suggesting the role of specific genetic factors in cigarette smoking. Health Psychology. 18: 14-20. PMID 9925041 DOI: 10.1037/0278-6133.18.1.14 |
0.512 |
|
| 1998 |
Brunet JS, Ghadirian P, Rebbeck TR, Lerman C, Garber JE, Tonin PN, Abrahamson J, Foulkes WD, Daly M, Wagner-Costalas J, Godwin A, Olopade OI, Moslehi R, Liede A, Futreal PA, et al. Effect of smoking on breast cancer in carriers of mutant BRCA1 or BRCA2 genes. Journal of the National Cancer Institute. 90: 761-6. PMID 9605646 DOI: 10.1093/Jnci/90.10.761 |
0.364 |
|
| 1998 |
Lerman C, Caporaso N, Main D, Audrain J, Boyd NR, Bowman ED, Shields PG. Depression and self-medication with nicotine: the modifying influence of the dopamine D4 receptor gene. Health Psychology. 17: 56-62. PMID 9459071 DOI: 10.1037//0278-6133.17.1.56 |
0.465 |
|
| 1998 |
Audrain J, Lerman C, Gomez-Caminero A, Boyd NR, Orleans CT. The Role of Trait Anxiety in Nicotine Dependence1 Journal of Applied Biobehavioral Research. 3: 29-42. DOI: 10.1111/J.1751-9861.1998.Tb00042.X |
0.45 |
|
| 1998 |
Lerman C, Main D, Audrain J, Caporaso NE, Bowman ED, Lockshin B, Shields PG, Boyd NR. Evidence Suggesting The Role Of Specific Genetic Factors In Cigarette Smoking Psychosomatic Medicine. 60: 104. DOI: 10.1097/00006842-199801000-00068 |
0.473 |
|
| 1997 |
Lerman C, Shields PG, Main D, Audrain J, Roth J, Boyd NR, Caporaso NE. Lack of association of tyrosine hydroxylase genetic polymorphism with cigarette smoking. Pharmacogenetics. 7: 521-524. PMID 9429239 DOI: 10.1097/00008571-199712000-00012 |
0.485 |
|
| 1997 |
Audrain J, Boyd NR, Roth J, Main D, Caporaso NE, Lerman C. Genetic susceptibility testing in smoking-cessation treatment: One-year outcomes of a randomized trial Addictive Behaviors. 22: 741-751. PMID 9426791 DOI: 10.1016/S0306-4603(97)00060-9 |
0.5 |
|
| 1997 |
Lerman C, Gold K, Audrain J, Lin TH, Orleans CT, Boyd NR, Wilfond B, Louben G, Caporaso N. Incorporating Biomarkers of Exposure and Genetic Susceptibility into Smoking Cessation Treatment: Effects on Smoking-Related Cognitions, Emotions, and Behavior Change Health Psychology. 16: 87-99. PMID 9028818 DOI: 10.1037//0278-6133.16.1.87 |
0.501 |
|
| 1996 |
Lerman C, Audrain J, Orleans CT, Boyd R, Gold K, Main D, Caporaso N. Investigation of mechanisms linking depressed mood to nicotine dependence Addictive Behaviors. 21: 9-19. PMID 8729703 DOI: 10.1016/0306-4603(95)00032-1 |
0.473 |
|
| Show low-probability matches. |
